Home > Clinical Trials
Check All Search

Saved trials

ACTIVE_NOT_RECRUITING
NCT05710666
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
11 Enrollment(s)
5 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Breast Cancer
NOT_YET_RECRUITING
NCT06533826
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
357 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


HER2-low Breast Cancer


Metastatic Breast Cancer
모집추가없이 진행중
KCT0009357
프라바스타틴과 관련하여 수행하였던 4 개 관찰연구 결과의 통합 분석 데이터를 활용한 국내 이상지질혈증 환자에서 심혈관질환 위험도 구분에 따른 프라바스타틴의 안전성 및 유효성 평가 연구
15,475 Enrollment(s)
1 Study location(s)
관찰연구 (None)
ACTIVE_NOT_RECRUITING
NCT06504719
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
312 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Breast Cancer


Metastatic Cancer
COMPLETED
NCT04640571
Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition
18 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Bile Salt Export Pump (BSEP) Transporter


Polysorbate 80
NOT_YET_RECRUITING
NCT06494111
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
295 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Lymphedema


Fibrosis
TERMINATED
NCT03944512
Pravastatin to Prevent Preeclampsia
50 Enrollment(s)
12 Study location(s)
INTERVENTIONAL (PHASE3)
Preeclampsia


Obstetric Labor Complications


Hypertension in Pregnancy
NOT_YET_RECRUITING
NCT06486883
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
200 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Breast Cancer


Advanced Breast Carcinoma


Hormone Receptor Positive Breast Carcinoma